Washington University School of Medicine: Pancreatic Neoplasms trials

The registry lists 31 Pancreatic Neoplasms studies with Washington University School of Medicine as lead sponsor. 4 are open to participants now and 13 have results posted.

Phase 1 16Phase 2 9No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic AdenocarcinomaRecruitingNCT07126158Phase 2
• MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal AdenocarcinomaRecruitingNCT06648434Phase 1
• Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal AdenocarcinomaRecruitingNCT06141031Phase 1
• MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRialRecruitingNCT05975593Not applicable
• Role of Proton Pump Inhibitors on the Postoperative Course Following PancreaticoduodenectomyTerminatedNCT05251233Phase 2Results posted
• Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) InhibitionCompletedNCT04542291Phase 1Results posted
• Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer PatientsTerminatedNCT04536077Phase 2Results posted
• Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant ChemotherapyTerminatedNCT03956056Phase 1Results posted
• Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant ChemotherapyTerminatedNCT03122106Phase 1Results posted
• Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal MalignanciesTerminatedNCT02950025Phase 2Results posted
• MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived TumorsTerminatedNCT02669914Phase 2Results posted
• BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic CancerTerminatedNCT02608229Phase 1Results posted
• Tosedostat With Capecitabine in Patients With Metastatic Pancreatic AdenocarcinomaTerminatedNCT02352831Phase 1/2Results posted
• Whipple Procedure: Standard of Care vs. ThunderbeatTerminatedNCT02204124Not applicableResults posted
• VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine TumorsTerminatedNCT01784861Phase 1/2Results posted
• Reinforced Staple Line on Leak Rate in Distal PancreatectomyTerminatedNCT01359410Not applicableResults posted
• Gemcitabine and Pazopanib in Metastatic Pancreatic CancerTerminatedNCT01080248Phase 2Results posted
• Enhanced Assistance During Radiotherapy for Unmet Essential NeedsCompletedNCT06582849Not applicable
• GI Organ Tracking Via Balloon ApplicatorsWithdrawnNCT05471401Not applicable
• Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to SurgeryCompletedNCT05111353Phase 1
• Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas AdenocarcinomaActive, not recruitingNCT04331041Phase 2
• Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiotherapy Workflow in a Novel Ring Gantry Radiotherapy DeviceCompletedNCT04008537Not applicable
• Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based TherapyCompletedNCT03883919Phase 1
• Epidural Analgesia Use in Pancreatic ResectionsCompletedNCT02681796Phase 1
• Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic CancerCompletedNCT02283372Phase 1
• Diagnosis of Bile Duct StricturesCompletedNCT02000999
• Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid MalignanciesCompletedNCT01677559Phase 1
• FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic AdenocarcinomaCompletedNCT01413022Phase 1
• Registry Study - Whipple at the Splenic ArteryCompletedNCT01155882
• Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas CancerTerminatedNCT00892242Phase 1
• Lag-3 and Gemcitabine for Treatment of Advanced Pancreas CancerTerminatedNCT00732082Phase 1